NautaDutilh-Led Biopharma Raises €25M For Alzheimer's Drug
German biopharma company Vivoryon said on Friday that it has raised €25 million ($26.8 million) to speed up the development of its Alzheimer's treatment, as well as help meet its financial...To view the full article, register now.
Already a subscriber? Click here to view full article